Cargando…

Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study

The phase III West Japan Oncology Group (WJOG) 4407G study showed noninferiority of folinic acid, bolus/continuous fluorouracil, and irinotecan plus bevacizumab to modified folinic acid, bolus/continuous fluorouracil, and oxaliplatin 6 plus bevacizumab in progression-free survival (PFS) as first-lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosokawa, Ayumu, Yamazaki, Kentaro, Matsuda, Chu, Ueda, Shinya, Kusaba, Hitoshi, Okamura, Shu, Tsuda, Masahiro, Tamura, Takao, Shinozaki, Katsunori, Tsushima, Takahiro, Tsuda, Takashi, Shirakawa, Tsuyoshi, Yamashita, Haruhiro, Morita, Satoshi, Hironaka, Shuichi, Muro, Kei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478588/ https://www.ncbi.nlm.nih.gov/pubmed/32899071 http://dx.doi.org/10.1097/MD.0000000000022060

Ejemplares similares

Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G
por: Arai, Hiroyuki, et al.
Publicado: (2021)

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild‐type KRAS colorectal cancer‐WJOG 6210G
por: Shitara, Kohei, et al.
Publicado: (2016)

Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study
por: Yoshitaka, Hashimoto, et al.
Publicado: (2017)

An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7)
por: Kawakami, Hisato, et al.
Publicado: (2021)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)
por: Okamoto, W., et al.
Publicado: (2022)

The efficacy and safety of bevacizumab combined with FOLFOX regimen in the treatment of advanced colorectal cancer: A systematic review and meta-analysis
por: Zhang, Hailing, et al.
Publicado: (2021)

Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials
por: Zhu, Xiaoqiang, et al.
Publicado: (2016)

Successful combination of endoscopic and laparoscopic removal of multiple ingested needles: A case report
por: Tsuruya, Kota, et al.
Publicado: (2020)

Clinical efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
por: Du, Sihao, et al.
Publicado: (2023)

Long-term prognosis after endoscopic resection of T1a-MM/T1b-SM1 esophageal squamous cell carcinoma
por: Ohki, Daisuke, et al.
Publicado: (2022)

Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G
por: Taniguchi, Hiroya, et al.
Publicado: (2020)

Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)
por: Takahashi, Naoki, et al.
Publicado: (2023)

A phase II clinical study of combining FOLFIRI and bevacizumab plus erlotinib in 2nd-line chemotherapy for patients with metastatic colorectal cancer
por: Zhao, Zhifei, et al.
Publicado: (2017)

4407 Adapting CAPABLE as CAPABLE-FAMILY for the caregiver-care recipient dyad with Alzheimer’s dementia
por: Rivers, Emerald, et al.
Publicado: (2020)

Does Rectal Indomethacin Given for Prevention of Post-ERCP Pancreatitis Increase Bleeding After Biliary Endoscopic Sphincterotomy or Cardiovascular Mortality?: Post Hoc Analysis Using Prospective Clinical Trial Data
por: Patai, Árpád, et al.
Publicado: (2014)

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group
por: Hirata, Kenro, et al.
Publicado: (2020)

Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure
por: Kobayashi, Noritoshi, et al.
Publicado: (2017)

Traction method versus conventional endoscopic submucosal dissection for gastric epithelial neoplasms: A randomized controlled trial
por: Kinoshita, Jun, et al.
Publicado: (2022)

Duodenal ulcer bleeding from a branch of the middle colic artery: A case report
por: Shishido, Yutaka, et al.
Publicado: (2023)

Long-Term Survival Following Pancreatectomy and S-1 Chemotherapy for Pancreatic Acinar Cell Carcinoma With Peritoneal Dissemination: A Case Report and Literature Review
por: Sumiyoshi, Tatsuaki, et al.
Publicado: (2015)

Upper Gastrointestinal Symptoms Predictive of Candida Esophagitis and Erosive Esophagitis in HIV and Non-HIV Patients: An Endoscopy-Based Cross-Sectional Study of 6011 Patients
por: Takahashi, Yuta, et al.
Publicado: (2015)

Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission
por: Miyazu, Takahiro, et al.
Publicado: (2021)

Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: A single-center observational study
por: Ishida, Natsuki, et al.
Publicado: (2021)

The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease: A prospective cohort study
por: Ishida, Natsuki, et al.
Publicado: (2020)

Successful management of thrombocytopenia by partial splenic embolization in patients with advanced gastric cancer and invasion of the splenic vein: Case reports
por: Nakatsubo, Ryosuke, et al.
Publicado: (2021)

Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults?: Randomized, double-blind, placebo-controlled trial
por: Ito, Daisaku, et al.
Publicado: (2022)

Clinicopathological significance of cystatin A expression in progression of esophageal squamous cell carcinoma
por: Shiba, Daiki, et al.
Publicado: (2018)

Fully covered self-expandable metal stent with an anti-migration system vs plastic stent for distal biliary obstruction caused by borderline resectable pancreatic cancer: A protocol for systematic review
por: Tamura, Takashi, et al.
Publicado: (2020)

A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case report
por: Nakatsubo, Ryosuke, et al.
Publicado: (2023)

Both MLH1 deficiency and BRAFV600E mutation are a unique characteristic of colorectal medullary carcinoma: An observational study
por: Kaneko, Masanao, et al.
Publicado: (2023)

Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (WJOG 5910L)
por: Takeda, Masayuki, et al.
Publicado: (2012)

Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease
por: Kawaguchi, Kazunori, et al.
Publicado: (2021)

Assessment of the application for renewal of the authorisation of Actisaf(®) Sc 47 (Saccharomyces cerevisiae CNCM I‐4407) as a feed additive for calves for rearing
por: Bampidis, Vasileios, et al.
Publicado: (2020)

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
por: Iwasa, Satoru, et al.
Publicado: (2023)

Assessment of the application for renewal of authorisation of Actisaf(®) Sc47 (Saccharomyces cerevisiae CNCM I‐4407) for lambs for fattening, minor dairy ruminants, horses and pigs for fattening
por: Rychen, Guido, et al.
Publicado: (2018)

Safety and efficacy of Actisaf(®) Sc47 (Saccharomyces cerevisiae CNCM I‐4407) as a feed additive for cattle for fattening, dairy cows, weaned piglets and sows
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Solitary Perihepatic Splenosis Mimicking Liver Lesion: A Case Report and Literature Review
por: Wu, Chao, et al.
Publicado: (2015)

Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease
por: Chung, Goh Eun, et al.
Publicado: (2015)

Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature
por: Grieco, Antonio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8p4sp0qovptigh7h7ev3ulea4u